Bio Green Med Solution
(NASDAQ) BGMS
Bio Green Med Solution Financials at a Glance
Market Cap
$5.02M
Revenue (TTM)
$1.53M
Net Income (TTM)
-$3.11M
EPS (TTM)
-$4.40
P/E Ratio
-0.21
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$0.78
Volume
279,085
Open
$0.89
Price
$0.78
Volume
279,085
Open
$0.89
Previous Close
$0.78
Daily Range
$0.77 - $0.90
52-Week Range
$0.73 - $19.87
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$0.78
Volume
279,085
Open
$0.89
Previous Close
$0.78
Daily Range
$0.77 - $0.90
52-Week Range
$0.73 - $19.87
Estimated Earnings Date
Aug 12, 2026
BGMS News
Cyclacel Announces New Stock Issue
5 of Last Week's Biggest Losers
4 Biotechs' Dominant Moves
ASCO Pops and Drops
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio Green Med Solution
Industry
Biotechnology
Sector
Health CareCEO
Sing Ee Wong, DBA
Website
www.cyclacel.comHeadquarters
Kuala Lumpur, 592000, US
BGMS Financials
Key Financial Metrics (TTM)
Gross Margin
18%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-288%
Return on Capital
-54%
Return on Assets
-41%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
-2.60%
Stock Overview
Market Cap
$5.02M
Shares Outstanding
5.52M
Volume
279.08K
Avg. Volume
2.26M
Financials (TTM)
Gross Profit
$138.00K
Operating Income
-$8.43M
EBITDA
-$8.42M
Operating Cash Flow
-$4.77M
Capital Expenditure
$0.00
Free Cash Flow
-$4.77M
Cash & ST Invst.
$3.51M
Total Debt
$2.00K
Bio Green Med Solution Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$778.00K
N/A
Gross Profit
$143.00K
N/A
Gross Margin
18.38%
N/A
Market Cap
$5.02M
N/A
Market Cap/Employee
$418.61K
N/A
Employees
12
N/A
Net Income
-$197.00K
-143.2%
EBITDA
-$245.00K
+95.1%
Quarterly Fundamentals
Total Cash
$3.34M
-3.2%
Total Debt
$0.00
-100.0%
Accounts Receivable
$1.19M
N/A
Inventory
$947.00K
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-41.17%
N/A
Return on Invested Capital
-53.74%
N/A
Free Cash Flow
-$279.00K
+91.4%
Operating Cash Flow
-$278.00K
+91.4%